Cite
HARVARD Citation
Press, R. et al. (n.d.). Next‐generation sequencing‐defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse. American journal of hematology. 94 (8), pp. 902-912. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Press, R. et al. (n.d.). Next‐generation sequencing‐defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse. American journal of hematology. 94 (8), pp. 902-912. [Online].